Cancer Vaccine Industry, November 2014 Market Reports from Top Publishers

You might be interested in: Cancer, Therapeutics, Drug, more »


 
1-10 of about 100 reports for Cancer Vaccine

Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits

Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Medical's imenvax device delivers immune catalysts which activates the patient's immune cell. The company's areas of operations include immuno-therapeutic cancer vaccine for canines, veterinary clinics ...

ImmunoVaccine Technologies Inc. (Symbol:IMV) SWOT Analysis, Strategy, Revenues and Profits

ImmunoVaccine Technologies Inc. (Symbol:IMV) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Designed to train the immune system to recognize and attack cancer cells and dpx-survivac is a clinical-stage cancer vaccine. Imv's depovax platfrom is a patented vaccine delivery formulation that provides ...

Omnimmune Holdings, Inc. (Symbol:OMMH) SWOT Analysis, Strategy, Revenues and Profits

Omnimmune Holdings, Inc. (Symbol:OMMH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... And a multivalent cancer vaccine targeting two epitopes of her-2, vald tumor associated antigens. The company principally focuses on the development of personalized cancer treatment with the selection ...

Product and Pipeline Analysis of the Global Vaccines MarketĀ : Expected Launches in the Areas of Cancer and Allergies Will Drive Growth

Product and Pipeline Analysis of the Global Vaccines MarketĀ : Expected Launches in the Areas of Cancer and Allergies Will Drive Growth

  • $ 6 000
  • Industry report
  • October 2014
  • by Frost & Sullivan

... Dashboardcancer vaccine product dashboardallergy vaccine product dashboardother vaccine product dashboardtimeline of key eventsconclusions new market opportunitiesthe frost ...

Cancer Vaccines Drug Pipeline Update 2014

Cancer Vaccines Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • October 2014
  • by Bioseeker

... cancer vaccines drug pipeline update 2014 cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. However, despite ...

Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014

Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

... Assessment by molecule type 24drug profiles 26peptide based therapeutic cancer vaccine - drug profile 26product description 26mechanism of action 26r&d progress 26vaccine to target prostate ...

Cancer Drug News 20 OCTOBER 2014

Cancer Drug News 20 OCTOBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

... Cancer drug news 20 october 2014 industry trend analysis - fully personalised cancer vaccines on the riseindustry trend analysis - pfizer's palbociclib on route for 2015 launchindustry brief ...

Key Pharma News 06 OCTOBER 2014

Key Pharma News 06 OCTOBER 2014

  • $ 1 415
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

... To secure its reign over hiv-1 marketindustry trend analysis - cancer vaccine gains first uk promising innovative medicine designationindustry brief - merck presents first phase iii data in japanese ...

Cancer Drug News 29 SEPTEMBER 2014

Cancer Drug News 29 SEPTEMBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

... Us licensing deal for mm-398industry trend analysis - cancer vaccine gains first uk promising innovative medicine designationindustry brief - fda grants odd to mabvax' neuroblastoma vaccine ...

Cancer Drug News 15 SEPTEMBER 2014

Cancer Drug News 15 SEPTEMBER 2014

  • $ 1 114
  • Industry report
  • September 2014
  • by Espicom Business Intelligence

... Industry brief - sellas/msk sign global licensing deal for wt1 cancer vaccineindustry brief - tracon initiates trc105 phase ii trial in stsindustry trend analysis - tesaro's rolapitant on course to compete ...

About 500 reports for Cancer Vaccine

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Europe

  • Background Paper 6 5 Cancer and Cancer Therapeutics
  • April 2013
    62 pages
  • Cancer  

  • Europe  

    World  

    United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.